Pre-conference workshop on the role of timeline therapy in anxiety relief 

Bahawalpur, October 31, 2022 (PPI-OT):Department of Applied Psychology, Faculty of Social Sciences, Islamia University, Bahawalpur, organized a pre-conference workshop on the role of Timeline Therapy in alleviating anxiety. The workshop was part of the second international conference on the relationship between psychology and other social sciences to be held next month under the Department of Applied Psychology.

On this occasion, the eminent neuropsychologist Dr. Muhammad Rafiq Dar gave a special lecture. The chairman of the department, Prof. Dr. Muhammad Saleem, expressed special thanks to the Vice Chancellor Engineer Prof. Dr. Athar Mehboob and Dean Faculty of Social Sciences Prof. Dr. Rubina Bhatti for their special guidance and patronage in organizing the pre-conference.

For more information, contact:
The Islamia University of Bahawalpur (IUB)
University Chowk, Gulshan Colony, Bahawalpur,
Punjab – 63100, Pakistan
Tel: +92-62-9250235
Fax: +92-62-9250335
E-mail: info@iub.edu.pk
Website: https://www.iub.edu.pk/

Breast cancer awareness seminar held at the Islamia University of Bahawalpur 

Bahawalpur, October 31, 2022 (PPI-OT):Breast cancer in Pakistani women proves to be life-threatening. Due to modern scientific development, early diagnosis and treatment of this disease is possible. However, due to lack of awareness in this regard, this disease is spreading rapidly in Pakistan and other Asian countries. According to the annual report of the World Health Organization, one million women are suffering from breast cancer in Pakistan every year. This was expressed by the speakers in the awareness seminar held at College of Art and Design the Islamia University of Bahawalpur.

The seminar was presided over by Begum Vice Chancellor Mrs. Rabia Athar. On this occasion, Dean Faculty of Social Sciences Prof. Dr. Rubina Bhatti, Principal College of Art and Design Ms. Maria Ansari, Dr. Amna Noor, Deputy Registrar Fatima Muzahir and faculty members were present. Director of Women Healthcare Center Dr. Safina Sheikh gave a detailed lecture in the seminar. The speakers said that breast cancer awareness campaign needs to be carried out vigorously.

In this regard, media and educational institutions can play an important role so that women can be aware of the seriousness of this disease. Unfortunately, our society is extremely backward regarding this disease, on the one hand, there are very few facilities for diagnosis and treatment, and on the other hand, our women hesitate to tell about this disease due to social traditionalism. On this occasion, the College of Art and Design building was decorated with pink banners. An art exhibition was also organized to raise awareness about breast cancer. Begum Vice Chancellor Mrs. Rabia Athar inaugurated the art exhibition.

For more information, contact:
The Islamia University of Bahawalpur (IUB)
University Chowk, Gulshan Colony, Bahawalpur,
Punjab – 63100, Pakistan
Tel: +92-62-9250235
Fax: +92-62-9250335
E-mail: info@iub.edu.pk
Website: https://www.iub.edu.pk/

Almost 80% Pakistani’s report that they have not been taking any medicine nowadays. Out of the ones who do, Panadol and Tenormin were revealed to be the most common medicines people take: Gallup and Gilani Pakistan 

Islamabad, October 31, 2022 (PPI-OT):According to a survey conducted by Gallup and Gilani Pakistan, almost 80% report that they have not been taking any medicine nowadays. Out of the ones who do, Panadol and Tenormin were revealed to be the most common medicines people take.

A nationally representative sample of adult men and women from across the country was asked the following question regarding, “Are you taking any type of medicine nowadays?” 17% said yes while 83% responded no.

The respondents who responded yes were asked a follow up question: “If yes, which medicine?” 4% responded Panadol and Tenormin, 3% responded homeopathic, blood pressure medicine, insulin medicine and multivitamins while 1% responded that they had taken arinac.

For more information, contact:
Head Office,
Gallup Pakistan
Islamabad, Pakistan
Tel: +92-51-8445080
Email: isb@gallup.com.pk, caf@gallup.com.pk
Website: www.gallup.com.pk

Conagen’s fermentation platform expands on promising novel forms of vitamin K2

Bedford, Mass., Oct. 31, 2022 (GLOBE NEWSWIRE) — Biotech innovator, Conagen announced the development of its fermentation-derived vitamin K2 – a high-purity all-trans menaquinone-7 (MK-7).  This is the first molecule from a proprietary platform for producing novel, pure, long-chain menaquinone forms of the vitamin. The platform enables low-cost manufacturing and yields high-quality products, making it attractive to health brands.

“Conagen’s MK-7 technology produces a clean profile of the vitamin without other similar molecules, such as ubiquinone,” said Casey Lippmeier, Ph.D., senior vice president of innovation at Conagen. “Our process allows us to make pure forms of any long-chain menaquinone, be it 6, 7, 8, 9, and these can be consumed in various combinations with other vitamins or with each other to make the most effective supplement possible. As the clinical evidence evolves, so can the supplement.”

Vitamin K2 helps to regulate calcium mobility in bones and restricts calcium buildup in blood vessels, leading to stroke and heart disease. MK-7 is the more bioavailable form of K2 on the market; the other major form is MK-4, which both have taken a strong position in the markets for bone and cardiovascular health.

The biological activity of MK-7 is strictly linked to its all-trans configuration, which is naturally found in fermented superfoods such as natto. Cis-analogues are considered biologically inactive. Synthetic versions of MK-7 contain some amount of the cis-isomer form. Low-quality sources containing cis forms affect the efficacy of the vitamin.

Other long-chain forms of vitamin K2, such as MK-8 and MK-9, exist naturally in cheeses. Research on the health benefits of these other K2 forms has only begun to emerge.

Personalized nutrition is popular with consumers looking for technological breakthroughs in functional foods and nutrition. Conagen’s cost-effective fermentation-derived MK-7 provides new opportunities for brands to develop products to meet the demand of the growing aging population.

“We’re demonstrating our capabilities with innovative technologies that expand market choices in nutrition,” said Lippmeier. “Our fermentation and bioconversion platforms have also produced the clean nutrient ergothioneine and the antioxidant taxifolin, further demonstrating the versatility of our platform technologies.”

Conagen’s research into the MK-7 production process was done in part as a 3-year collaboration with the lab of Prof. Anthony Sinskey at the Massachusetts Institute of Technology.

Health brands interested in non-GMO, vegan vitamin K2 MK-4 and MK-7 and special ingredients, such as ErgoActive® L-Ergothioneine® and Taxifolin BC DHQ® for nutrition and food and beverage preservation, respectively, can contact Blue California, a pipeline partner of Conagen. To inquire more about Conagen’s products or partnerships, please visit www.conagen.com.

About Conagen

Conagen is a product-focused, synthetic biology R&D company with large-scale manufacturing service capabilities. Our scientists and engineers use the latest synthetic biology tools to develop high-quality, sustainable, nature-based products by precision fermentation and enzymatic bioconversion. We focus on the bioproduction of high-value ingredients for food, nutrition, flavors and fragrances, pharmaceutical, and renewable materials industries.

Attachments

Ana Arakelian, Head of Public Relations and Communications
Conagen
+1.949.750.6812
ana.arakelian@conagen.com

GlobeNewswire Distribution ID 8685378

Dominica’s Anichi Resort & Spa provides a 2% annual return while under construction

Roseau, Oct. 31, 2022 (GLOBE NEWSWIRE) — Anichi Resort & Spa will be providing a 2% annual return to investors despite being under construction. The management of the much-anticipated five-star luxury resort and spa in Dominica has said that the project is in full swing, and that once construction is completed, annual returns will be based on the resort’s operation.

Following an official update, an estimated 70% of the project is now complete; this includes the flooring as well as an extensive electricity infrastructure. The resort is being built on 12 acres of land, with 128 rooms. I will host world-class amenities, such as a lagoon swimming pool, an infinity pool, restaurants, a business centre and many others. Overlooking a picturesque beach, the resort will tastefully blend its modern architecture with the landscape’s tropical foliage.

Developed by Oriental Developers (Caribbean) Ltd, the resort will form part of the Autograph Collection, a premium international brand developed by renowned hotelier Marriott International. This links the resort to more than 100 luxury lifestyle hotels across 30 countries and territories – all of which have been constructed as part of Autograph Collection Hotels. Furthermore, Anichi Resort will be managed by Highgate, a dominant player in major US gateway cities with a growing footprint in the Caribbean and Latin America.

Anichi Resort & Spa is also one of the premium real estate options approved by the Dominican government’s Citizenship by Investment (CBI) programme. The CBI Index of 2022, published by the PWM Magazine of the Financial Times, recognises it as the “World’s Best Citizenship by Investment Programme”. The minimum investment threshold for Anichi Resort & Spa is $220,000 (USD), an expenditure which also comes with lifetime Dominican citizenship and property ownership.

The resort will bolster the tourism sector and generate extensive employment for locals. The country already occupies a notable position, ranking first among 25 other Caribbean islands – winning due to its lush green jungles, hot springs and striking black-sand beaches. Annually, scores of investors fly to Dominica owing to its large number of government-approved investment projects. The Citizenship by Investment Programme of Dominica allows these individuals to purchase freehold shares in government-approved properties.

Anichi Resort & Spa provides investors and CBI applicants with a Return on Investment (ROI) as well as a route towards diversifying their portfolios and planning their wealth

The Prime Minister of Dominica, Dr Roosevelt Skerrit, praised the CBI Programme, “Thanks to the real-estate investment option of the Citizenship by Investment Programme,” he noted, “the country is catching the attraction of travel-enthusiasts and is now known for [its] luxury tourism offering. Under the Citizenship Programme, investors looking to expand their real estate portfolio have the opportunity to invest in established luxury hotel brands and villas.” 

Dominica’s real estate investment option has long provided premium, luxury projects for investment. A prior example of this is Secret Bay, a real estate property which paid out more than $1 million (USD) in returns to investors. The Residences at Secret Bay also promises great returns, having drawn more than 100 Citizenship by Investment (CBI) owners. The resort has already won a number of awards, and it is anticipated that Anichi Resort & Spa will likewise be counted as one of the jewels in Dominica’s real estate crown.

Anichi Resort promises to be a meaningful asset during this time of global uncertainty. CS Global Partners, a legal consulting firm working in the investment citizenship field, noted that, beyond the resort’s world-class architecture and lush surrounding environment, “[t]he project also brings in interest from investors keen to participate in the development through Dominica’s Citizenship by Investment (CBI) Programme. Once completed, the resort promises to transform Dominica’s tourism sector while also boosting employment for the local community”.

Concurrently, Dominica is witnessing the construction of several other hotels, including a Hilton hotel, which will also fall under the government-approved real estate investment options of the country’s CBI programme. Many of these properties are being built to be sustainable and climate-resilient, with the continued construction of such resorts and hotels positioning the island as a top destination for eco-luxury resorts.

Dominica’s real estate is thus proving to be a popular option among investors and high net-worth individuals (HNWIs). Bolstering investment is the strength of the country’s CBI programme. The credibility and trustworthiness of Dominica’s programme has been maintained since its launch almost three decades ago, and it has been ranked the world’s best CBI programme for its sixth consecutive year. Alongside alternative citizenship, the Citizenship by Investment Programme of Dominica provides a number of other opportunities to investors. These include:

  • The ability to become a global citizen and be part of a global community transcends Dominica’s land borders.
  • The ability to hold multiple citizenships.
  • A citizenship that is granted for life and can be passed on to future generations.
  • An opportunity to provide families and children with a peaceful, stable, safe and welcoming home.
  • Access to countless business opportunities, with the option of portfolio diversification.
  • Enhanced opportunities for wealth planning and expanding business overseas.
  • A stable currency, with Dominica’s currency, the East Caribbean Dollar (XCD), pegged to USD.

These factors, combined with alternative citizenship, present individuals with a rich array of business and personal advantages. As the success and promise of the Anichi Resort & Spa attest, the island along with its CBI programme offers investment with unrivalled returns.

PR Dominica
Commonwealth of Dominica
001 (767) 266 3919
mildred.thabane@csglobalpartners.com
.

GlobeNewswire Distribution ID 8685334

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Rite Aid Corporation Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – RAD

NEW YORK, Oct. 30, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Rite Aid Corporation (NYSE: RAD) between April 14, 2022 and September 28, 2022, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than December 19, 2022.

SO WHAT: If you purchased Rite Aid securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Rite Aid class action, go to https://rosenlegal.com/submit-form/?case_id=9388 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than December 19, 2022. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) despite representations to the contrary, the number of new members (i.e., “lives”) that Elixir’s (a subsidiary of the Company) pharmacy benefit management (“PBM”) services business was adding during the selling season ending on January 1, 2023 was in material decline; (2) Rite Aid was likely to recognize a significant charge for the impairment of goodwill related to Elixir due to a decrease in “lives” covered by Elixir’s PBM services business; and (3) as a result, the Company’s public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Rite Aid class action, go to https://rosenlegal.com/submit-form/?case_id=9388 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

        Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com

GlobeNewswire Distribution ID 8684860